Search Results 451-460 of 16821 for Antagonist

  1. Transcatheter Aortic Valve Replacement Clinical Trials - Mayo Clinic Research

    Some patients also get new heart valves using a catheter. Often doctors give patients a medicine called a vitamin K antagonist (VKA), because it is considered ...

  2. Open-Label Tolvaptan Study in Subjects With ADPKD - Mayo Clinic

    Subjects who have taken a vasopressin antagonist (outside of previous participation in a tolvaptan trial); Subjects unable to comply with anti-hypertensive ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer - Mayo Clinic

    Participation eligibility · Use of 5-alpha reductase antagonist (i.e. finasteride, dutasteride) within 3 months of study entry · Use of antiandrogen (e.g. ...

  5. Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome - Mayo Clinic

    ... antagonist over the last 4 weeks and no episode of decompensated Congestive Heart Failure (CHF) over the past 6 months. Calculated creatinine clearance of ...

  6. Long-term control medications · Inhaled corticosteroids · Leukotriene modifiers · Long-acting beta agonists (LABAs) · Long-acting muscarinic antagonists (LAMAs).

  7. Mayo Clinic Q and A: Long-Term Antibiotic Use For Some With COPD

    The classes include the antibiotic azithromycin. The other classes are inhaled corticosteroids, long-acting beta agonists, long-acting muscarinic antagonists, ...

  8. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) - Mayo Clinic

    DRD2 antagonist within past 2 weeks. 6. Any investigational therapy within past 4 weeks. 7. Strong CYP3A4 inhibitors within 3 days. 8. Strong CYP3A4 ...

  9. A Study to Compare Elacestrant vs. Standard of Care for the Treatment of Patients with ER+/HER2- Advanced Breast Cancer - Mayo Clinic

    Prior treatment with elacestrant or investigational SERD or ER antagonist (for example, D-0502, GDC-0810, GDC-0927, GDC-9545,G1T-48, LSZ102, AZD9496, SAR439859, ...

  10. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    ... antagonist (ERA), soluble guanylate cyclase (sGC) stimulator, prostanoids, prostacyclin receptor agonists and must be on stable doses (≥3 months) at ...